Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2023-02-01
سلاسل:	Frontiers in Surgery
الموضوعات:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!